Wall Street analysts adjust ratings on key stocks, with Palantir upgraded to Buy and Walmart downgraded before its August 20 earnings report.
Deutsche Bank upgraded Palantir (PLTR) to Buy from Hold, maintaining a $200 price target. The firm cited Palantir’s “exceptional” Q2 report as the catalyst for the upgrade.
Oppenheimer downgraded Walmart (WMT) to Perform from Outperform ahead of its August 20 earnings release. The firm did not provide a new price target, signaling caution on the retail giant’s near-term outlook. Other notable moves included UBS upgrading BBB Foods (TBBB) to Buy with a raised price target of $51, and Wolfe Research lifting Madrigal Pharmaceuticals (MDGL) to Outperform with a $605 target.
The adjustments reflect shifting sentiment around growth prospects, valuation, and upcoming earnings, with analysts highlighting both upside potential and downside risks in their calls.